Akebia Therapeutics Inc at Jefferies Healthcare Conference Transcript
Hey, everyone. My name is Claire, and I'm with the Jefferies Investment Banking Team. Welcome to the Jefferies Global Healthcare Conference. And it is my great pleasure to introduce John Butler, CEO of Akebia Therapeutics.
And with that, I'll hand it over to him.
Thank you, Claire. Thanks so much for the invitation, and thanks, everyone, for joining us this morning. I'm excited to talk to you about Akebia Therapeutics.
I just want to remind you that I'm going to be making forward-looking statements, so please refer to our SEC filings for more information.
I actually really am very excited to talk to you about Akebia this morning. Just over a week ago, we had an incredibly important moment where the FDA responded to our dispute resolution around the CRL for vadadustat and gave us a clear path forward. This is an incredibly important moment for the company, one that really changes our trajectory. And I look forward to spending a fair amount
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |